Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma

被引：0
|
作者：
J. Cho
S. Y. Kim
Y. J. Kim
M. H. Sim
S. T. Kim
N. K. D. Kim
K. Kim
W. Park
J. H. Kim
K.-T. Jang
J. Lee
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Samsung Medical Center,Oncology, Department of Medicine, Samsung Medical Center
[3] Samsung Medical Center,Samsung Biomedical Research Institute
[4] Sungkyunkwan University School of Medicine,Samsung Genome Institute
[5] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
来源：
Clinical and Translational Oncology | 2017年 / 19卷
关键词：
KIT; Melanoma; Imatinib; Acquired resistance; CTNNB1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1247 / 1252
页数：5
相关论文
共 50 条
  • [41] Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis
    Penel, Nicolas
    Bonvalot, Sylvie
    Bimbai, Andre-Michel
    Meurgey, Alexandra
    Le Loarer, Francois
    Salas, Sebastien
    Piperno-Neumann, Sophie
    Chevreau, Christine
    Boudou-Rouquette, Pascaline
    Dubray-Longeras, Pascale
    Kurtz, Jean-Emmanuel
    Guillemet, Cecile
    Bompas, Emmanuelle
    Italiano, Antoine
    Le Cesne, Axel
    Orbach, Daniel
    Thery, Julien
    Le Deley, Marie-Cecile
    Blay, Jean-Yves
    Mir, Olivier
    CLINICAL CANCER RESEARCH, 2022, 28 (18) : 4105 - 4111
  • [42] A case of ovarian steroid cell tumor with bizarre nuclear atypia and CTNNB1 mutation
    Suzuki, Masaki
    Matsushima, Jun
    Yazawa, Takuya
    Ota, Satoshi
    Kiyokawa, Takako
    Sonehara, Hiroki
    Hanawa, Shinsuke
    Mitsuhashi, Akira
    Shozu, Makio
    Nakatani, Yukio
    PATHOLOGY INTERNATIONAL, 2017, 67 (05) : 278 - 279
  • [43] Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation
    Kojima, Naoki
    Yoshida, Hiroshi
    Uno, Masaya
    Hiranuma, Kengo
    Naka, Tomoaki
    Shiraishi, Kouya
    Kato, Tomoyasu
    VIRCHOWS ARCHIV, 2022, 481 (05) : 799 - 804
  • [44] Mutation analysis of CTNNB1 (β-catenin) and AXINI, the components of Wnt pathway, in cervical carcinomas
    Su, TH
    Chang, JG
    Yeh, KT
    Lin, TH
    Lee, TP
    Chen, JC
    Lin, CC
    ONCOLOGY REPORTS, 2003, 10 (05) : 1195 - 1200
  • [45] Establishment of an iPSC line from a NDD patient with a heterozygous mutation in the CTNNB1 gene
    Ning, Jiaying
    Zhou, Tiancheng
    Luo, Xianqiong
    Ma, Jian
    Zhang, Zhishuai
    Gao, Liwei
    Zhu, Yanling
    STEM CELL RESEARCH, 2024, 79
  • [46] Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
    Kim, Grace
    Kurnit, Katherine C.
    Djordjevic, Bojana
    Singh, Charanjeet
    Munsell, Mark F.
    Wang, Wei-Lien
    Lazar, Alexander J.
    Zhang, Wei
    Broaddus, Russell
    MODERN PATHOLOGY, 2018, 31 (10) : 1553 - 1559
  • [47] NUTLIN-3A AS A NOVEL ANTICANCER AGENT FOR ADRENOCORTICAL CARCINOMA WITH CTNNB1 MUTATION
    Feng, Chenchen
    Chen, Shanwen
    JOURNAL OF UROLOGY, 2017, 197 (04): : E475 - E475
  • [48] Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
    McConechy, Melissa K.
    Ding, Jiarui
    Senz, Janine
    Yang, Winnie
    Melnyk, Nataliya
    Tone, Alicia A.
    Prentice, Leah M.
    Wiegand, Kimberly C.
    McAlpine, Jessica N.
    Shah, Sohrab P.
    Lee, Cheng-Han
    Goodfellow, Paul J.
    Gilks, C. Blake
    Huntsman, David G.
    MODERN PATHOLOGY, 2014, 27 (01) : 128 - 134
  • [49] A refractory liver metastatic solid pseudopapillary neoplasm pancreas harbored CTNNB1 mutation showed good response to celecoxib: A case report
    Shang, Yu
    Zhang, Yunkun
    Pan, Evenki
    Yang, Peng
    Xu, Lingling
    Sun, Jinghua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor
    Cardoso, Leila C. A.
    De Souza, Kelly R. L.
    Reis, Adriana Helena De O.
    Andrade, Raissa Coelho
    Britt, Alberto C., Jr.
    De Lima, Maria A. F. D.
    Dos Santos, Anna C. E.
    De Faria, Paulo S.
    Ferman, Sima
    Seuanez, Hector N.
    Vargas, Fernando R.
    ONCOLOGY REPORTS, 2013, 29 (01) : 315 - 320
12345